Dr. Amy Armstrong, MD
Claim this profileWashington University School of Medicine
About Amy Armstrong, MD
Education:
- Received an MD from Washington University School of Medicine.
Experience:
- Serves as a Pediatric Oncologist at Washington University Physicians, with a focus on oncology and pediatric cancer.
- Practices at St. Louis Children's Hospital and St. Louis Children's Specialty Care Center – West County.
- Engaged in providing a comprehensive range of clinical services, including access to innovative treatments and clinical trials.
- Collaborates with a school liaison to support the educational needs of patients during their treatment journey.
Area of expertise
Osteosarcoma
Amy Armstrong, MD has run 10 trials for Osteosarcoma. Some of their research focus areas include:
Soft Tissue Sarcoma
Amy Armstrong, MD has run 8 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Case Western Reserve University
Clinical Trials Amy Armstrong, MD is currently running
Chemotherapy
for Wilms Tumor
This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo (ifosfamide, carboplatin, etoposide, cyclophosphamide, and topotecan) work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT (those treated with only 2 drugs for the initial WT) and regimen ICE/Cyclo/Topo has on patients with high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT).
Recruiting
1 award
Phase 2
12 criteria
Sirolimus + Chemotherapy
for High-Risk Pediatric Cancers
The primary objective of this study is to improve the 2-year progression-free survival in children with high-risk solid tumors who are administered a maintenance regimen with continuous sirolimus administered on a backbone of metronomic chemotherapy following the completion of "standard" therapy, as compared to high-risk solid tumor patients treated with observation alone following completion of "standard" therapy.
Recruiting
3 awards
Phase 2
More about Amy Armstrong, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Amy Armstrong, MD has experience with
- Carboplatin
- Cyclophosphamide
- Paclitaxel
- Etoposide
- Gemcitabine
- Pembrolizumab
Breakdown of trials Amy Armstrong, MD has run
Osteosarcoma
Soft Tissue Sarcoma
Solid Tumors
Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy Armstrong, MD specialize in?
Amy Armstrong, MD focuses on Osteosarcoma and Soft Tissue Sarcoma. In particular, much of their work with Osteosarcoma has involved Stage IV patients, or patients who are Stage I.
Is Amy Armstrong, MD currently recruiting for clinical trials?
Yes, Amy Armstrong, MD is currently recruiting for 9 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Amy Armstrong, MD has studied deeply?
Yes, Amy Armstrong, MD has studied treatments such as Carboplatin, Cyclophosphamide, Paclitaxel.
What is the best way to schedule an appointment with Amy Armstrong, MD?
Apply for one of the trials that Amy Armstrong, MD is conducting.
What is the office address of Amy Armstrong, MD?
The office of Amy Armstrong, MD is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.